IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?

被引：1

作者：

Kow, Chia Siang ^{[1
,2
]}

Zaihan, Abdullah Faiz ^{[3
]}

Ramachandram, Dinesh Sangarran ^{[2
]}

Hasan, Syed Shahzad ^{[4
,5
]}

机构：

[1] Int Med Univ, Sch Postgrad Studies, Kuala Lumpur, Malaysia

[2] Monash Univ Malaysia, Sch Pharm, Jalan Lagoon Selatan, Subang Jaya, Selangor, Malaysia

[3] Shah Alam Hosp, Dept Pharm, Seksyen 7, Shah Alam, Selangor, Malaysia

[4] Univ Huddersfield, Sch Appl Sci, Huddersfield, W Yorkshire, England

[5] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia

来源：

CYTOKINE | 2022年 / 149卷

关键词：

Corticosteroid; COVID-19; IL-6; antagonist; Sarilumab; Tocilizumab;

D O I：

10.1016/j.cyto.2021.155730

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页数：2

共 11 条

[1]

Demirbas K.C, J INFECT CHEMOTHER

[2]

Hasan, MALAYSIAN J PHARM, V7, P1

[3] Accelerating the Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: A Risk of Combining Dexamethasone and Tocilizumab for Severe Coronavirus Disease 2019 [J].

Koeckerling, David ;

Barker, Joseph .

JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (06) :934-937

[4] The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials [J].

Kow, Chia Siang ;

Hasan, Syed Shahzad .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (08) :1089-1094

[5]

KOW CS, CHEST, V159, P2108

[6]

Kow CS., 2020, CLIN INFECT DIS, Vciaa1423, DOI [DOI 10.1093/CID/CIAA1423, 10.1093/cid/ciaa1423]

[7]

LU ZY, 1995, BLOOD, V86, P3123

[8]

Merchant, EXPERT REV RESP MED, P1

[9] Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis [J].

Sterne, Jonathan A. C. ;

Murthy, Srinivas ;

Diaz, Janet, V ;

Slutsky, Arthur S. ;

Villar, Jesus ;

Angus, Derek C. ;

Annane, Djillali ;

Pontes Azevedo, Luciano Cesar ;

Berwanger, Otavio ;

Cavalcanti, Alexandre B. ;

Dequin, Pierre-Francois ;

Du, Bin ;

Emberson, Jonathan ;

Fisher, David ;

Giraudeau, Bruno ;

Gordon, Anthony C. ;

Granholm, Anders ;

Green, Cameron ;

Haynes, Richard ;

Heming, Nicholas ;

Higgins, Julian P. T. ;

Horby, Peter ;

Juni, Peter ;

Landray, Martin J. ;

Le Gouge, Amelie ;

Leclerc, Marie ;

Lim, Wei Shen ;

Machado, Flavia R. ;

McArthur, Colin ;

Meziani, Ferhat ;

Moller, Morten Hylander ;

Perner, Anders ;

Petersen, Marie Warrer ;

Savovic, Jelena ;

Tomazini, Bruno ;

Veiga, Viviane C. ;

Webb, Steve ;

Marshall, John C. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (13) :1330-1341

[10] The use of remdesivir for the management of patients with moderate-to-severe COVID-19: a systematic review [J].

Thiruchelvam, Kaeshaelya ;

Kow, Chia Siang ;

Hadi, Muhammad Abdul ;

Hasan, Syed Shahzad .

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (02) :211-229

← 1 2 →